135 related articles for article (PubMed ID: 3416075)
1. Cytogenetic studies and their prognostic significance in agnogenic myeloid metaplasia: a report on 47 cases.
Demory JL; Dupriez B; Fenaux P; Laï JL; Beuscart R; Jouet JP; Deminatti M; Bauters F
Blood; 1988 Sep; 72(3):855-9. PubMed ID: 3416075
[TBL] [Abstract][Full Text] [Related]
2. Cytogenetics of agnogenic myeloid metaplasia: a study of 61 patients.
Djordjevic V; Dencic-Fekete M; Jovanovic J; Bizic S; Jankovic G; Bogdanovic A; Cemerikic-Martinovic V; Gotic M
Cancer Genet Cytogenet; 2007 Feb; 173(1):57-62. PubMed ID: 17284371
[TBL] [Abstract][Full Text] [Related]
3. Cytogenetic findings and their clinical relevance in myelofibrosis with myeloid metaplasia.
Tefferi A; Mesa RA; Schroeder G; Hanson CA; Li CY; Dewald GW
Br J Haematol; 2001 Jun; 113(3):763-71. PubMed ID: 11380468
[TBL] [Abstract][Full Text] [Related]
4. Cytogenetic and molecular genetic abnormalities in agnogenic myeloid metaplasia.
Reilly JT
Semin Oncol; 2005 Aug; 32(4):359-64. PubMed ID: 16202681
[TBL] [Abstract][Full Text] [Related]
5. Prognostic diversity among cytogenetic abnormalities in myelofibrosis with myeloid metaplasia.
Tefferi A; Dingli D; Li CY; Dewald GW
Cancer; 2005 Oct; 104(8):1656-60. PubMed ID: 16104040
[TBL] [Abstract][Full Text] [Related]
6. Presence of unfavorable cytogenetic abnormalities is the strongest predictor of poor survival in secondary myelofibrosis.
Dingli D; Schwager SM; Mesa RA; Li CY; Dewald GW; Tefferi A
Cancer; 2006 May; 106(9):1985-9. PubMed ID: 16568439
[TBL] [Abstract][Full Text] [Related]
7. The impact of cytogenetic abnormalities on the prognosis of primary myelofibrosis: a prospective survey of 202 cases in Japan.
Hidaka T; Shide K; Shimoda H; Kameda T; Toyama K; Katayose K; Kubuki Y; Nagata K; Takenaka K; Akashi K; Okamura T; Niho Y; Mizoguchi H; Omine M; Ozawa K; Harada M; Shimoda K
Eur J Haematol; 2009 Oct; 83(4):328-33. PubMed ID: 19549278
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system.
Dupriez B; Morel P; Demory JL; Lai JL; Simon M; Plantier I; Bauters F
Blood; 1996 Aug; 88(3):1013-8. PubMed ID: 8704209
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetic abnormalities and their prognostic significance in idiopathic myelofibrosis: a study of 106 cases.
Reilly JT; Snowden JA; Spearing RL; Fitzgerald PM; Jones N; Watmore A; Potter A
Br J Haematol; 1997 Jul; 98(1):96-102. PubMed ID: 9233570
[TBL] [Abstract][Full Text] [Related]
10. The role of cytogenetic abnormalities as a prognostic marker in primary myelofibrosis: applicability at the time of diagnosis and later during disease course.
Tam CS; Abruzzo LV; Lin KI; Cortes J; Lynn A; Keating MJ; Thomas DA; Pierce S; Kantarjian H; Verstovsek S
Blood; 2009 Apr; 113(18):4171-8. PubMed ID: 19131547
[TBL] [Abstract][Full Text] [Related]
11. Refined cytogenetic-risk categorization for overall and leukemia-free survival in primary myelofibrosis: a single center study of 433 patients.
Caramazza D; Begna KH; Gangat N; Vaidya R; Siragusa S; Van Dyke DL; Hanson C; Pardanani A; Tefferi A
Leukemia; 2011 Jan; 25(1):82-8. PubMed ID: 20944670
[TBL] [Abstract][Full Text] [Related]
12. In B-cell chronic lymphocytic leukaemia chromosome 17 abnormalities and not trisomy 12 are the single most important cytogenetic abnormalities for the prognosis: a cytogenetic and immunophenotypic study of 480 unselected newly diagnosed patients.
Geisler CH; Philip P; Christensen BE; Hou-Jensen K; Pedersen NT; Jensen OM; Thorling K; Andersen E; Birgens HS; Drivsholm A; Ellegaard J; Larsen JK; Plesner T; Brown P; Andersen PK; Hansen MM
Leuk Res; 1997; 21(11-12):1011-23. PubMed ID: 9444933
[TBL] [Abstract][Full Text] [Related]
13. Cytogenetic studies and their prognostic contribution in 565 Chinese patients with primary myelofibrosis.
Li B; Xu J; Li C; Gale RP; Xu Z; Qin T; Zhang Y; Huang G; Fang L; Zhang H; Pan L; Hu N; Qu S; Xiao Z
Am J Hematol; 2014 Nov; 89(11):1043-6. PubMed ID: 25132428
[TBL] [Abstract][Full Text] [Related]
14. Prognostic relevance of cytogenetics determined by fluorescent in situ hybridization in patients having myelofibrosis with myeloid metaplasia.
Strasser-Weippl K; Steurer M; Kees M; Augustin F; Tzankov A; Dirnhofer S; Fiegl M; Simonitsch-Klupp I; Gisslinger H; Zojer N; Ludwig H
Cancer; 2006 Dec; 107(12):2801-6. PubMed ID: 17103442
[TBL] [Abstract][Full Text] [Related]
15. Cytogenetic abnormalities in essential thrombocythemia: prevalence and prognostic significance.
Gangat N; Tefferi A; Thanarajasingam G; Patnaik M; Schwager S; Ketterling R; Wolanskyj AP
Eur J Haematol; 2009 Jul; 83(1):17-21. PubMed ID: 19236446
[TBL] [Abstract][Full Text] [Related]
16. Karyotype complements the International Prognostic Scoring System for primary myelofibrosis.
Hussein K; Huang J; Lasho T; Pardanani A; Mesa RA; Williamson CM; Ketterling RP; Hanson CA; Van Dyke DL; Tefferi A
Eur J Haematol; 2009 Apr; 82(4):255-9. PubMed ID: 19215287
[TBL] [Abstract][Full Text] [Related]
17. The pattern and clinical significance of karyotypic abnormalities in patients with idiopathic and postpolycythemic myelofibrosis.
Miller JB; Testa JR; Lindgren V; Rowley JD
Cancer; 1985 Feb; 55(3):582-91. PubMed ID: 3965109
[TBL] [Abstract][Full Text] [Related]
18. [Cytogenetics and molecular genetics in myelofibrosis with myeloid metaplasia and polycythemia vera].
Roche-Lestienne C; Andrieux J
Pathol Biol (Paris); 2007 Feb; 55(1):49-55. PubMed ID: 16901657
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetic studies in five patients with myelofibrosis and myeloid metaplasia.
Carbone P; Barbata G; Mirto S; Marcenò R; Leone S; Granata G
Cancer Genet Cytogenet; 1984 Jul; 12(3):209-15. PubMed ID: 6722762
[TBL] [Abstract][Full Text] [Related]
20. Clinical and biological characteristics of adult de novo and secondary acute myeloid leukemia with balanced 11q23 chromosomal anomaly or MLL gene rearrangement compared to cases with unbalanced 11q23 anomaly: confirmation of the existence of different entities with 11q23 breakpoint.
Archimbaud E; Charrin C; Magaud JP; Campos L; Thomas X; Fière D; Rimokh R
Leukemia; 1998 Jan; 12(1):25-33. PubMed ID: 9436917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
